Volastra Therapeutics today announced the dosing of the first patient in a Phase I/II clinical trial evaluating VLS-1488.

--atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced the completion of the Phase 1 study of VLS-01 in healthy ...

In a bid to improve the Mogami class's anti-submarine warfare (ASW) capabilities, Japan has begun installing the vertical launching system (VLS) on selected hulls of the ...

The Phase 1b trial of VLS-01 investigates the pharmacokinetics, pharmacodynamics, safety and tolerability of atai’s proprietary, optimized oral transmucosal formulation of DMT VLS-01 is being ...

The UK Royal Navy (RN) has revealed plans to install the Lockheed Martin Mk 41 vertical launching system (VLS) into its five new Type 31 Inspiration-class general-purpose frigates.